Recombinant HIV-2 E Protein (aa 390-702) (VAng-Lsx0252)
Recombinant Human Immunodeficiency Virus Type 2 (HIV-2) envelope antigen (amino acids 390-702). 34kDa with Beta-galactosidase (114kDa) fused at the N-terminus, was expressed in E. coli.
Datasheet
Specifications
Source
Gorillas
Target
Human Immunodeficiency Virus
Type
Viral Antigens
Applications
ELISA, WB, SDS-PAGE, Immunogen, etc.
Formulation
0.01M Na2CO3, 0.01M Na3EDTA, 0.014M beta- mercaptoethanol, 0.05 % Tween 20.
Purity
> 95 % pure by SDS-PAGE.
Storage
Store at 2 °C to 8 °C short term, -20 °C long term.
Antigen Information
Introduction
The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS). HIV infect human which leads to paralysis of the immune system by destructing T lymphocytes, and then blocks processes of the cellular immune and humoral immune, eventually leads to AIDS. Recently, there are four HIV strains, named M, N, O and P type, all come from Cameroon chimpanzees and gorillas. Each of these four species has unique source, and we now know that the most widely spread of M and N have been confirmed from chimpanzees, while the rare O and P types have been confirmed from gorillas of southwestern Cameroon.
Alternative Names
HIV-2 Envelope 201 Antigen; Retroviridae; Lentivirus; Human immunodeficiency virus 2
Related Product
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
